Difference between revisions of "PDFF Biomarker Ctte"
Jump to navigation
Jump to search
| Line 12: | Line 12: | ||
*[[Media:2017_07-06_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|07.06.2017 QIBA PDFF Biomarker Ctte Call Summary]] | *[[Media:2017_07-06_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|07.06.2017 QIBA PDFF Biomarker Ctte Call Summary]] | ||
| − | + | [[PDFF Biomarker Committee Call Summaries Archive]] | |
| − | |||
| − | |||
==Working Documents== | ==Working Documents== | ||
Revision as of 15:16, 3 November 2017
- Co-chairs: Scott Reeder, MD, PhD, Takeshi Yokoo, MD, PhD
- Secretary: Susan Weinmann
The PDFF Biomarker Committee seeks to develop a quantitative Profile for PDFF.
Recent Meetings/Call Summaries
- 09.07.2017 QIBA PDFF Biomarker Ctte Call Summary
- 08.03.2017 QIBA PDFF Biomarker Ctte Call Summary
- 07.06.2017 QIBA PDFF Biomarker Ctte Call Summary
PDFF Biomarker Committee Call Summaries Archive